Biogen

In News

Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting - Biogen

Biogen - Dec 05, 2025

Lido Advisors LLC Has $647,000 Stock Holdings in Biogen Inc. $BIIB - MarketBeat

MarketBeat - Dec 07, 2025

How Biogen is returning to its roots with a West Coast immunology outpost - Fierce Biotech

Fierce Biotech - Nov 18, 2025

Biogen (BIIB): Assessing Valuation After Recent Share Price Gains - Yahoo Finance

Yahoo Finance - Dec 02, 2025

Stoke, Biogen Present Positive Long-Term Results For Zorevunersen In Dravet Syndrome - Nasdaq

Nasdaq - Dec 05, 2025

Should New LEQEMBI Data and Subcutaneous Option Shift the Risk Profile for Biogen (BIIB) Investors? - simplywall.st

simplywall.st - Dec 04, 2025

Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions - Biogen

Biogen - Nov 24, 2025

Biogen Inc. $BIIB Stake Reduced by Schroder Investment Management Group - MarketBeat

MarketBeat - Dec 07, 2025

A Look at Biogen (BIIB) Valuation Following New Dravet Syndrome Study Results - Yahoo Finance

Yahoo Finance - Nov 18, 2025

Sarah Kleinpeter: Driving the Future of Alzheimer's Care - Biogen

Biogen - Dec 02, 2025

Biogen Inc. $BIIB Shares Bought by Guggenheim Capital LLC - MarketBeat

MarketBeat - Dec 06, 2025

High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy - Biogen

Biogen - Nov 17, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment